Acrivon Therapeutics, Inc. (NASDAQ:ACRV) IPO

Acrivon Therapeutics, Inc.

IPO

Priced at US$12.50 a share on Nov 14, 2022.

Price
US$12.50 a share
Shares offered
7,550,000 shares of common stock
Offering size
US$94.4 million
Underwriters' option
Up to 1,132,500 more shares
Underwriters
JEFFERIES, COWEN, PIPER SANDLER · In the order on the cover
Shares delivered
On or about Nov 17, 2022

Steps

StepWhen
Draft sent to the SEC in confidenceAug 12, 2022
Filed publiclyOct 17, 2022
Amended twiceNewest Nov 8, 2022
Shares registered with an exchangeNov 7, 2022
Declared effective by the SECNov 9, 2022
Final prospectus, with the priceNov 16, 2022

From the cover of the final prospectus (424B4) filed Nov 16, 2022